Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen t
about
Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside ResistanceMassively parallel digital high resolution melt for rapid and absolutely quantitative sequence profilingDiagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter StudyTransmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results.Whole-Genome Sequencing Analysis Accurately Predicts Antimicrobial Resistance Phenotypes in Campylobacter sppPerformance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.Geographic Differences in the Contribution of ubiA Mutations to High-Level Ethambutol Resistance in Mycobacterium tuberculosisDetection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.Fighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis.In vitro drug susceptibility of Mycobacterium tuberculosis for amikacin, kanamycin and capreomycin.
P2860
Q28546999-71A7433A-13C9-429F-B6D4-2E6A21B008C5Q28817256-9E769408-32FB-487C-800E-EE2FA899652CQ35693044-9126A23D-9E9F-4D42-A52F-7FBDA9692815Q35868609-51289603-B219-4102-9339-302530F83286Q36457739-619DBB33-F86B-400D-8B4F-FE536C6D9E0CQ36933151-3685CF6B-7CB8-43EA-BBEB-E99D5DF2833FQ37023233-E751B6CE-B369-4D68-B004-6F7991395361Q37581864-7E215CFA-E234-4F0E-8CE8-C3CFD209C147Q37612943-3E291609-9705-49B6-ACFF-9DC85958B7ACQ38545953-BB570040-0BEC-4D4A-BE1B-1F4767AFDD50Q50134142-7F59780D-99C3-4DDB-AE0B-6E4FF0641800
P2860
Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen t
description
im Januar 2015 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2015
@uk
name
Genotypic susceptibility testi ...... phenotypic Lowenstein-Jensen t
@en
Genotypic susceptibility testi ...... phenotypic Lowenstein-Jensen t
@nl
type
label
Genotypic susceptibility testi ...... phenotypic Lowenstein-Jensen t
@en
Genotypic susceptibility testi ...... phenotypic Lowenstein-Jensen t
@nl
prefLabel
Genotypic susceptibility testi ...... phenotypic Lowenstein-Jensen t
@en
Genotypic susceptibility testi ...... phenotypic Lowenstein-Jensen t
@nl
P2093
P2860
P356
P1476
Genotypic susceptibility testi ...... phenotypic Lowenstein-Jensen t
@en
P2093
Cheon Tae Kim
David Alland
Eun Jin Cho
Jong Seok Lee
Laura E Smith
Laura E Via
Sandy S Roh
Sang-Nae Cho
Soumitesh Chakravorty
P2860
P356
10.1128/JCM.02059-14
P407
P577
2015-01-01T00:00:00Z